This content is in French.
CRISPR Against Malaria: The End of the Mosquito?
22 avril 2026
By Ana Espino | Published on April 22, 2026 | 4 min readMalaria is one of the deadliest infectious diseases in the world, responsible for approximately 600,000 deaths per year and transmitted by mosquitoes of the Anopheles genus. This disease has profoundly shaped human history and remains a major public health challenge today. Despite significant progress, current strategies have notable limitati
Malaria is one of the deadliest infectious diseases in the world, responsible for approximately 600,000 deaths per year and transmitted by mosquitoes of the Anopheles genus. This disease has profoundly shaped human history and remains a major public health challenge today. Despite significant progress, current strategies have notable limitations. Drug treatments, although effective, are not sufficient to interrupt transmission, while vector control tools such as insecticides and bed nets are becoming less effective due to the emergence of resistance. Moreover, some historical approaches relied on environmentally harmful methods that are no longer considered acceptable.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Smidler AL, et al. CRISPR technologies for the control and study of malaria-transmitting anopheline mosquitoes. Parasit Vectors. 2025 Jul 3;18(1):252. doi: 10.1186/s13071-025-06905-w. PMID: 40611351; PMCID: PMC12226854.
View on PubMed
